Troluce Capital Advisors »

Springworks Therapeutics shares owned by Troluce Capital Advisors

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by Troluce Capital Advisors from 13F filings

Historical chart of Troluce Capital Advisors investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by Troluce Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by Troluce Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-03-31 $1.8M 42k 44.13

More positions owned by Troluce Capital Advisors

Fluor Corporation Call Option (FLR)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Kenvue (KVUE)
Honeywell International Call Option (HON)
Echostar Corp Cl A (SATS)
Capital One Financial (COF)
Dupont De Nemours (DD)
Oklo Com Cl A Put Option (OKLO)
Golar Lng SHS Call Option (GLNG)
EXACT Sciences Corporation Call Option (EXAS)
Amcor Ord (AMCR)
Standardaero (SARO)
Intel Corporation Call Option (INTC)
Equinix (EQIX)
U Haul Holding Company Com Ser N (UHAL.B)

View all positions for Troluce Capital Advisors

Top funds holding Springworks Therapeutics

DekaBank Deutsche Girozentrale
Advisor Group Holdings
Huntington National Bank

View all funds holding Springworks Therapeutics